Published on 14 Jun 2021 on Insider Monkey via Yahoo Finance
Is Aethlon Medical, Inc. (AEMD) A Good Stock To Buy?
In this article we will check out the progression of hedge fund sentiment towards Aethlon Medical, Inc. (NASDAQ:AEMD) and determine whether it is a good investment right now. We at Insider Monkey like to examine what billionaires and hedge funds think of a company before spending days of research on it. Given their 2 and 20 payment structure, hedge funds have more incentives and resources than the average investor. The funds have access to expert networks and get tips from industry insiders. They also employ numerous Ivy League graduates and MBAs. Like everyone else, hedge funds perform miserably at times, but their consensus picks have historically outperformed the market after risk adjustments.
Is AEMD a good stock to buy? The best stock pickers were becoming more confident. The number of bullish hedge fund positions advanced by 2 recently. Aethlon Medical, Inc. (NASDAQ:AEMD) was in 3 hedge funds' portfolios at the end of the first quarter of 2021. The all time high for this statistic was previously 1. This means the bullish number of hedge fund positions in this stock currently sits at its all time high. Our calculations also showed that AEMD isn't among the 30 most popular stocks among hedge funds (click for Q1 rankings). There were 1 hedge funds in our database with AEMD positions at the end of the fourth quarter.
In the eyes of most investors, hedge funds are viewed as slow, outdated financial tools of yesteryear. While there are over 8000 funds in operation at present, Our researchers hone in on the bigwigs of this group, approximately 850 funds. These investment experts manage the lion's share of the hedge fund industry's total asset base, and by tailing their first-class investments, Insider Monkey has identified various investment strategies that have historically outperformed Mr. Market. Insider Monkey's flagship short hedge fund strategy outrun the S&P 500 short ETFs by around 20 percentage points per annum since its inception in March 2017. Also, our monthly newsletter's portfolio of long stock picks returned 206.8% since March 2017 (through May 2021) and beat the S&P 500 Index by more than 115 percentage points. You can download a sample issue of this newsletter on our website .